HbA1c variability is associated with microalbuminuria development in type 2 diabetes: a 7-year prospective cohort study. (Q45926064)

17 December 2017

title

HbA1c variability is associated with microalbuminuria development in type 2 diabetes: a 7-year prospective cohort study. (English)

1 reference

17 December 2017

0 references

5

1 reference

17 December 2017

author name string

C C Hsu

1

1 reference

17 December 2017

H Y Chang

2

1 reference

17 December 2017

M C Huang

3

1 reference

17 December 2017

S J Hwang

4

1 reference

17 December 2017

Y S Lee

6

1 reference

17 December 2017

S J Shin

7

1 reference

17 December 2017

T Y Tai

8

1 reference

17 December 2017

publication date

26 August 2012

1 reference

17 December 2017

published in

Diabetologia

1 reference

17 December 2017

volume

55

1 reference

17 December 2017

issue

12

1 reference

17 December 2017

page(s)

3163-3172

1 reference

17 December 2017

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2700-4

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2700-4

Is fasting glucose variability a risk factor for retinopathy in people with type 2 diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2700-4

Glycaemic variability is associated with coronary artery calcium in men with Type 1 diabetes: the Coronary Artery Calcification in Type 1 Diabetes study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2700-4

The effects of fasting plasma glucose variability and time-dependent glycemic control on the long-term risk of retinopathy in type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2700-4

Association of glycemic variability and the presence and severity of coronary artery disease in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2700-4

Glycemic risk factors of diabetic vascular complications: the role of glycemic variability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2700-4

'Glycaemic variability': a new therapeutic challenge in diabetes and the critical care setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2700-4

For debate. Glucose variability and diabetes complication risk: we need to know the answer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2700-4

Glucose variability; does it matter?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2700-4

Glycaemic variability and complications in patients with diabetes mellitus: evidence from a systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2700-4

A1C variability predicts incident cardiovascular events, microalbuminuria, and overt diabetic nephropathy in patients with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2700-4

A1C variability as an independent risk factor for microalbuminuria in young people with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2700-4

A1C variability and the risk of microvascular complications in type 1 diabetes: data from the Diabetes Control and Complications Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2700-4

10-year follow-up of intensive glucose control in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2700-4

Prospective randomized controlled trial to evaluate effectiveness of registered dietitian-led diabetes management on glycemic and diet control in a primary care setting in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2700-4

Association between insulin resistance and development of microalbuminuria in type 2 diabetes: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2700-4

Changes in glycaemic control and risk of coronary artery disease in type 1 diabetes mellitus: findings from the Pittsburgh Epidemiology of Diabetes Complications Study (EDC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2700-4

Glucose variability does not contribute to the development of peripheral and autonomic neuropathy in type 1 diabetes: data from the DCCT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2700-4

A decrease in glucose variability does not reduce cardiovascular event rates in type 2 diabetic patients after acute myocardial infarction: a reanalysis of the HEART2D study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2700-4

Long-term instability of fasting plasma glucose, a novel predictor of cardiovascular mortality in elderly patients with non-insulin-dependent diabetes mellitus: the Verona Diabetes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2700-4

Fasting plasma glucose variability predicts 10-year survival of type 2 diabetic patients: the Verona Diabetes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2700-4

Fasting plasma glucose variability as a risk factor of retinopathy in Type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2700-4

Glycemic variability: the third component of the dysglycemia in diabetes. Is it important? How to measure it?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2700-4

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2700-4

Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2700-4

Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2700-4

Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2700-4

Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2700-4

The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22923064

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Relationship between glycated haemoglobin levels and mean glucose levels over time

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22923064

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The effect of glucose variability on the risk of microvascular complications in type 1 diabetes

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22923064

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00125-012-2700-4

1 reference

17 December 2017

Dimensions Publication ID

1035751483

0 references

1 reference

17 December 2017